Overview: Eurepa 0.5 Tablet is an antidiabetic medication used for the management of type 2 diabetes mellitus. It contains Repaglinide (0.5mg), which stimulates the pancreas to release insulin, thereby lowering blood sugar levels. Key Benefits: – Helps control post-meal blood glucose spikes – Quick onset of action – Suitable for use with diet and exercise in type 2 diabetes Composition: Repaglinide (0.5mg) How It Works: Repaglinide is a meglitinide class drug that acts on pancreatic beta cells to stimulate insulin secretion in response to meals, thereby managing blood glucose levels effectively. Usage Instructions: – Take before meals as prescribed by your doctor – Dosage may vary based on individual response and meals – Swallow with water; do not chew or crush Side Effects: – Hypoglycemia – Nausea – Headache – Dizziness Precautions: – Not for use in type 1 diabetes or diabetic ketoacidosis – Inform your doctor about liver or kidney issues – Monitor blood glucose levels regularly Storage Instructions: – Store below 25°C – Keep away from moisture and direct sunlight Manufacturer: Torrent Pharmaceuticals Ltd Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.